AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
about
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilizationAMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agentAccelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixaforMolecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial.Peripheral blood stem cell mobilization: new regimens, new cells, where do we standSelective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model.Cell-based therapy for heart disease: a clinically oriented perspectiveInfluence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.Ibrutinib inhibits SDF1/CXCR4 mediated migration in AMLGlobal transcriptional analysis for biomarker discovery and validation in cellular therapies.Ex vivo expansion of retrovirally transduced primate CD34+ cells results in overrepresentation of clones with MDS1/EVI1 insertion sites in the myeloid lineage after transplantation.Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro.CXC chemokine CXCL12 and its receptor CXCR4 in tree shrews (Tupaia belangeri): structure, expression and function.Significant mobilization of both conventional and regulatory T cells with AMD3100.Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjectsCXCR4 antagonists in hematologic malignancies: more than just mobilizers?Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cells in vitro.Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells.Potency analysis of cellular therapies: the emerging role of molecular assaysMobilization as a preparative regimen for hematopoietic stem cell transplantationThe chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftmentPlerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapyHematopoietic stem-cell behavior in nonhuman primatesHuman term placenta as a source of hematopoietic cellsAberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival.Rapid assay of stem cell functionality and potency using electric cell-substrate impedance sensingGetting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their nicheVector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis.Mobilization of hematopoietic stem/progenitor cells: general principles and molecular mechanisms.Hematopoietic niche and bone meetThe central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders?Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis.
P2860
Q26773952-CFCB2B0D-F689-4B05-AC4D-5C9EBCF17835Q26825518-148C17CB-AC5B-46F4-A4F0-38E84769A563Q28286940-79CF3D80-9912-4D0E-BFF0-405D77DDDF3BQ28742157-7CC6C149-0465-42D3-8BF6-C88F440DEA84Q30832371-E695F49B-7F98-4A24-881D-CE82CC66B85DQ33573756-F435799E-64E4-4400-BFCB-FC70598400DEQ33589591-423DFDFF-6383-46EC-B535-24F4C581DF09Q33623571-49D8ED76-1192-4921-A2B9-E075B3ACEABFQ33713519-E6DEB102-DF84-4F6A-A83E-23D7C33F1889Q34038572-15964203-25FF-4E06-A94B-60674852B992Q34042250-81D2BACA-6294-4F76-8CBB-9F315A38E466Q34171422-FCBBEB73-D27B-4B93-9754-1AB3CF02A2BCQ34209811-B7BBC9F1-62E4-424E-8A22-DFA958615C44Q34246928-9C7F0E9C-3BD3-472F-BCDD-5688BBE6098FQ34432943-47960D2E-AF4C-490B-8C8B-596C594ED913Q34494776-80D6E822-CA2F-42C7-A64C-DB196D976313Q35173452-EDB2381B-A89F-405D-9E0E-6DE48AC3EBA9Q35623657-5A963D86-FAE9-414F-97E7-E6926EFDCCADQ35665207-9D99931E-A9FA-4907-9394-BC2132922010Q35676019-AB9C9AF3-48C7-4932-916D-0FA889508CDDQ35676034-D576C7EE-1BF0-4FB8-8C2F-4B29568644CBQ35793034-F78C9E5F-7E8A-4542-9D95-4A0BC092019FQ35804766-F5C16C7F-5D37-4EF6-93FD-6DFEF49699B0Q35840586-721D78D1-70B0-4413-8F63-72A8B41D7428Q35849647-66151C19-4E5A-4B35-89E2-633104AA04A8Q35901690-A7A2577A-26DF-4245-BE47-C2B54EE2DF45Q35904935-FD3668DA-69DA-4D4D-A495-F521148A8693Q35990651-C4FC68CF-9869-4417-93BF-5616B84D18A3Q36075515-48196C27-6BF8-49B5-886A-56CA7A87CD71Q36085659-15F3B02F-E9D8-406A-BC16-961E7B116939Q36126357-4882B07D-59D9-47F7-9601-BB4BA2AF08F8Q36164628-EE374577-3A31-42D7-A72D-30CB740888F0Q36248825-AEE1275E-8E81-4034-87A5-70F5DAAA50B7Q36287703-D438DA22-4AE9-4186-8F01-1F9D6AA83595Q36445393-CB890B93-5949-4EEC-BF63-B91A56D2A7F0Q36823321-C6D516D6-8F55-43EF-AF6C-0C808F019172Q36912497-A9FFC147-B0DA-497B-989F-5D2B4BF51B36Q36948866-85BA85F6-2B6D-46A4-B0B9-3FBEE1610041Q37016290-D1A1EBC2-DF09-425E-8FFD-4B008DA9508CQ37046334-52F32C40-37FC-487A-9670-5C37C60EBC86
P2860
AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates.
@ast
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates.
@en
type
label
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates.
@ast
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates.
@en
prefLabel
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates.
@ast
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates.
@en
P2093
P2860
P1433
P1476
AMD3100 mobilizes hematopoieti ...... capacity in nonhuman primates
@en
P2093
Allen Krouse
André Larochelle
Donald Orlic
Gary Bridger
Mark Metzger
Peiman Hematti
Robert E Donahue
Simon Fricker
P2860
P304
P356
10.1182/BLOOD-2005-09-3592
P407
P577
2006-01-26T00:00:00Z